These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 6461412

  • 1. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
    Weijers MJ.
    Clin Ther; 1982; 4(5):359-66. PubMed ID: 6461412
    [Abstract] [Full Text] [Related]

  • 2. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
    Weijers MJ.
    Fortschr Med; 1982 Apr 29; 100(16):764-7. PubMed ID: 6211403
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G.
    Int J Fertil; 1989 Sep 29; 34 Suppl():31-9. PubMed ID: 2576255
    [Abstract] [Full Text] [Related]

  • 4. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H.
    Acta Obstet Gynecol Scand; 1988 Sep 29; 67(2):171-4. PubMed ID: 2972160
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
    Bilotta P, Favilli S.
    Arzneimittelforschung; 1988 Jul 29; 38(7):932-4. PubMed ID: 2974702
    [Abstract] [Full Text] [Related]

  • 6. Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
    Dieben TO, van Beek A, Coelingh Bennink HJ.
    Arzneimittelforschung; 1991 Sep 29; 41(9):996-8. PubMed ID: 1839126
    [Abstract] [Full Text] [Related]

  • 7. Clinical experience with an ethinyl estradiol-desogestrel oral contraceptive.
    Van Trappen Y, Duvivier P, Thiery M, Van Kets H, Defoort P, Parewijck W, Derom R, Kermans G, Schoofs P.
    Arzneimittelforschung; 1989 Jun 29; 39(6):717-9. PubMed ID: 2528355
    [Abstract] [Full Text] [Related]

  • 8. Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
    Skouby SO.
    Int J Fertil; 1987 Jun 29; 32 Suppl():45-8. PubMed ID: 2906346
    [Abstract] [Full Text] [Related]

  • 9. A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles.
    Woutersz TB.
    J Reprod Med; 1981 Dec 29; 26(12):615-20. PubMed ID: 7033528
    [Abstract] [Full Text] [Related]

  • 10. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
    Rákóczi I, Gerö G, Demeter J, Gáti I.
    Arzneimittelforschung; 1985 Dec 29; 35(3):630-3. PubMed ID: 3158320
    [Abstract] [Full Text] [Related]

  • 11. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
    Dieben TO, op ten Berg MT, Coelingh Bennink HJ.
    Arzneimittelforschung; 1994 Jul 29; 44(7):877-9. PubMed ID: 7945527
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
    Bilotta P, Favilli S.
    Minerva Ginecol; 1987 Dec 29; 39(12):855-69. PubMed ID: 3329705
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical experience with Mercilon and Marvelon with special reference to ovarian function].
    Mall-Haefeli M, Werner-Zodrow I, Huber PR.
    Geburtshilfe Frauenheilkd; 1991 Jan 29; 51(1):34-8. PubMed ID: 1827418
    [Abstract] [Full Text] [Related]

  • 14. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
    Shoupe D.
    Obstet Gynecol; 1994 May 29; 83(5 Pt 1):679-85. PubMed ID: 8164925
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene.
    Serfaty D, Vree ML.
    Eur J Contracept Reprod Health Care; 1998 Dec 29; 3(4):179-89. PubMed ID: 10036600
    [Abstract] [Full Text] [Related]

  • 16. [A clinical trial of a monophasic contraceptive preparation containing ethinyl estradiol and desogestrel].
    Bilotta P, Favilli S.
    Akush Ginekol (Mosk); 1992 Dec 29; (8-12):40-3. PubMed ID: 1292360
    [Abstract] [Full Text] [Related]

  • 17. [Clinical experiences with a gestodene containing oral contraceptive (femoden)].
    Gimes G, Valent S.
    Acta Pharm Hung; 1998 Sep 29; 68(5):289-93. PubMed ID: 9805815
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of a 2-phase preparation (Oviol 22) with a low-dose 1-phase preparation (Ovoresta M)].
    Dik M, Eckert H, Hönes S, Schindler AE.
    Geburtshilfe Frauenheilkd; 1984 Dec 29; 44(12):808-12. PubMed ID: 6570117
    [Abstract] [Full Text] [Related]

  • 19. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Dec 29; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 20. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
    Serup J, Bostofte E, Larsen S, Westergaard J.
    Acta Obstet Gynecol Scand; 1981 Dec 29; 60(2):203-6. PubMed ID: 7018165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.